GVR Report cover Coenzyme Q10 Market Size, Share & Trends Report

Coenzyme Q10 Market Size, Share & Trends Analysis Report By Application (Dietary Supplements, Pharmaceuticals, Cosmetics, Others), By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: 978-1-68038-245-7
  • Number of Pages: 80
  • Format: Electronic (PDF)

Coenzyme Q10 Market Size & Trends

The global coenzyme Q10 market size was valued at USD 614.2 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 10.2% from 2023 to 2030. Growing consumer awareness regarding the benefits offered by it in treating various ailments is expected to remain a key driving factor for the global coenzyme Q10 market over the forecast period.

U.S. Coenzyme Q10 market size and growth rate, 2023 - 2030

Inherent benefits of the product in healthcare applications such as the treatment of cancer, cardiovascular disease, and Huntington’s disease have also contributed to market growth. The coenzyme was conventionally utilized in the treatment of cardiovascular ailments and cognitive illnesses, as well as an effective component in treating periodontal diseases.

Estimates by the World Health Organization (WHO) predict that the number of cancer patients is likely to rise considerably by 2030. This factor is expected to fuel coenzyme Q10 demand in the future.

CoQ10 is responsible for transferring electrons and aerobic cellular respiration in diverse organisms. It is majorly found in organs that require high energy such as the liver, kidney, and heart. The product is industrially manufactured via yeast fermentation, although it can also be produced by bacteria fermentation for small-scale purposes.

The market is expected to witness significant growth in fast-growing applications such as cosmetics, which include anti-aging and sunscreen creams. Growing consumer disposable income on account of economic growth in emerging economies such as China, India, Mexico, and Brazil is driving the demand for natural & organic cosmetic ingredients, which in turn is crucial for the coenzyme Q10 industry. The growing geriatric population in countries such as the U.S., UK, Russia, China, and Japan coupled with the growing prevalence of ailments & diseases, particularly in developing economies of Asia Pacific, have resulted in high demand for nutricosmetics manufactured from coenzymes. The material has inherent antioxidant properties and provides biological energy to promote skin repair.

CoQ10 is sold only as a dietary supplement, restricting its potential applications in the medical industry. Stringent government & federal regulations regarding drug usage are expected to hinder growth over the forecast period. However, rising awareness regarding the benefits in eye care and cognitive disease treatment is expected to offer lucrative opportunities over the forecast period.

Regional Insights

North America dominated the market and accounted for the largest revenue share of 48.5% in 2022. The region is expected to maintain its dominance owing to the high demand for cosmetic applications. However, stringent regulations regarding product usage in medical ailments are expected to hinder growth.

Global Coenzyme Q10 market share and size, 2022

Asia Pacific is expected to grow at the CAGR of 11.0% during the forecast period. Transitioning consumer lifestyles, coupled with growing health concerns in emerging economies such as India and Japan is expected to drive segment growth. The development of small-scale manufacturers along with increasing cosmetics demand in India and China would be a positive sign for regional industry growth. Favorable regulatory guidelines along with a positive application outlook in personal care products is expected to propel the demand for coenzyme Q10 over the forecast period.

Application Insights

The dietary supplements segment held the largest revenue share of 60.9% in 2022. The segment growth is likely to be driven by advantageous product characteristics that include antioxidant and energy generation properties. There is an extensive demand for dietary supplements as well as in the pharmaceutical industry, the health drink manufacturers are also coming up with the new health drink which contains CoQ10.

The cosmetics segment is anticipated to register a CAGR of 10.4% over the forecast period. Pharmaceutical compositions are basically used for the treatment of diseases of the skin and mucous membranes and for preventing dysmetabolic conditions. The activity of coenzyme Q10 is stringently in relation to the tissular respiratory processes. Growing application scope in the ailment of cognitive diseases, eye care, cancer, and heart diseases, coupled with the rising number of cardiovascular disease patients is expected to fuel demand.

Key Companies & Market Share Insights

The market competition is high among the market players. The fragmented nature of the industry along with price-based competition in the vitamin supplements product market is likely to play a vital role in influencing the product demand over the forecast period. The market is highly concentrated with the top four companies accounting for over 60% of the overall volume.

Key Coenzyme Q10 Companies:

  • Gnosis
  • Hwail Pharmaceutical CO., LTD.
  • DSM Nutritional Products AG
  • PharmaEssentia Corporation
  • Nisshin Seifun Group Inc.

Recent Developments

  • In January 2023, the market for coenzyme Q10 dietary supplements experienced a significant surge in China, coinciding with a notable increase in COVID-19 cases throughout the country. This surge in demand can be attributed, in part, to the prevailing belief that coenzyme Q10 may possess the potential to mitigate myocarditis, an inflammation of the heart muscle, in individuals who have recuperated from COVID-19.

  • In January 2021, Kaneka Corporation launched their latest product, Watashi no Chikara (My Energy) - Q10 Yogurt, which provides consumers with a convenient means of incorporating the active form of coenzyme Q10 (Ubiquinol) into their diet. This new yogurt offering was made available through Kaneka Shokuhin Co., Ltd., an affiliate company, and sold across various retail channels, including bakeries, supermarkets, convenience stores, general retailers, as well as Kaneka's online shop.

Coenzyme Q10 Market Report Scope

Report Attribute


Market size value in 2023

USD 677.9 million

Revenue forecast in 2030

USD 1.33 billion

Growth rate

CAGR of 10.2% from 2023 to 2030

Base year for estimation


Historical data

2018 - 2021

Forecast period

2023 - 2030

Report updated

October 2023

Quantitative units

Revenue in USD million/billion, volume in tons, and CAGR from 2023 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Application, region

Regional scope

North America; Europe; Asia Pacific; Rest of the World

Country scope

U.S.; Canada; Mexico; U.K.; Germany; France; Italy; Belgium; Netherlands; China; Japan; India; Malaysia; South Korea; Brazil

Key companies profiled

KANEKA CORPORATION; MITSUBISHI GAS CHEMICAL COMPANY, INC.; Gnosis; Hwail Pharmaceutical CO., LTD.; KYOWA HAKKO U.S.A., INC.; DSM Nutritional Products AG; PharmaEssentia Corporation,; ZMC-USA LLC; Nisshin Seifun Group Inc.

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Global Coenzyme Q10 Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global coenzyme Q10 market based on application and region:

Global Coenzyme Q10 Market Report Segmentation

  • Application Outlook (Revenue, USD Million; Volume, Tons, 2018 - 2030)

    • Dietary Supplements

    • Pharmaceuticals

    • Cosmetics

    • Others

  • Regional Outlook (Revenue, USD Million; Volume, Tons, 2018 - 2030)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Belgium

      • Netherlands

    • Asia Pacific

      • Japan

      • China

      • India

      • Malaysia

      • Thailand

      • South Korea

    • Rest of the World

      • Brazil

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.